CD163 and metabolic dysfunction-associated steatotic liver disease: Although the contribution of adipose tissue macrophages to circulating sCD163 cannot be ruled out, the combination of results suggest that circulating sCD163 primarily represents liver macrophage activation in patients with NAFLD.